Epcoritamab
Epcoritamab, sold under the brand name Epkinly among others, is a Bi-specific T-cell engager (BiTE) used for the treatment of diffuse large B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager.
Epcoritamab, sold under the brand name Epkinly among others, is a Bi-specific T-cell engager (BiTE) used for the treatment of diffuse large B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager.
Epcoritamab, sold under the brand name Epkinly among others, is a Bi-specific T-cell engager (BiTE) used for the treatment of diffuse large B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager.
Source: Wikipedia "Epcoritamab" · CC BY-SA 4.0
Share this article: X · Bluesky